FDA Approved: FLECAINIDE ACETATE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved flecainide acetate under an Original Application (ANDA) for Chartwell RX, LLC, enabling a generic version of this antiarrhythmic to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Paroxysmal Supraventricular Tachycardia
• Ventricular Tachycardia

Drugs mentioned

• Flecainide acetate (flecainide acetate)

Snippet

ORIG AP for FLECAINIDE ACETATE (FLECAINIDE ACETATE)